BENIGN PROSTATE HYPERTROPHY(BPH)
Clinical trials for BENIGN PROSTATE HYPERTROPHY(BPH) explained in plain language.
Never miss a new study
Get alerted when new BENIGN PROSTATE HYPERTROPHY(BPH) trials appear
Sign up with your email to follow new studies for BENIGN PROSTATE HYPERTROPHY(BPH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New liquid embolic shows promise for prostate troubles
Disease control Not yet recruitingThis study tests a liquid material called SQUIDPERI for a procedure that blocks blood flow to the prostate (prostatic artery embolization) in men with an enlarged prostate. The goal is to see if it works better than standard particles at easing urinary symptoms like frequent or w…
Matched conditions: BENIGN PROSTATE HYPERTROPHY(BPH)
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Quantum leap in cancer detection: AI blood test could slash unnecessary biopsies
Diagnosis Not yet recruitingThis study is developing a new blood test that combines quantum sensors and artificial intelligence to detect prostate cancer. Researchers will analyze DNA fragments in blood samples from 1100 men to train an AI model. The goal is to create a non-invasive, accurate diagnostic too…
Matched conditions: BENIGN PROSTATE HYPERTROPHY(BPH)
Sponsor: Shanghai Changzheng Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
Natural supplement combo may match standard drug for prostate relief
Symptom relief Not yet recruitingThis study will compare two treatments for moderate to severe urinary symptoms caused by an enlarged prostate. One group takes a standard drug (alfalitic) plus a natural supplement (Serenoa repens, or saw palmetto), while the other takes the same drug plus another standard medica…
Matched conditions: BENIGN PROSTATE HYPERTROPHY(BPH)
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New prostate drug enters early safety testing
Knowledge-focused Not yet recruitingThis early-stage trial tests a new drug called CKD-846 in 32 healthy men with benign prostate hypertrophy (enlarged prostate). The main goal is to see how the drug moves through the body and if it is safe. Participants must be men aged 19 to 55 with a healthy weight.
Matched conditions: BENIGN PROSTATE HYPERTROPHY(BPH)
Phase: PHASE1 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC